RS

Ritu Singh Rana

Director Director DIN 07960772
DIN 07960772 First appointment Oct 2017 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2017
Shareholding value Locked Premium profile

About Ritu Singh Rana

Ritu Singh Rana has 8 years in corporate governance. Formerly with 1 company, such as Harbingers Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07960772
Primary Designation Director
First Appointment 09 Oct 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 09 Oct 2017 2015 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Harbingers Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ritu Singh Rana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Singh Rana

Ritu Singh Rana has 8 years in corporate governance. Formerly with 1 company, such as Harbingers Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ritu Singh Rana is associated with 0 companies as a director.

Ritu Singh Rana has expertise in General Business.

Ritu Singh Rana has 8 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available